Mark Shackleton
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Molecular Biology top 10%
- RNA modifications and cancer
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
- CRISPR and Genetic Engineering
Papers in
-
- Cancer Genomics and Diagnostics 3
- Genetics 2
- Genomic variations and chromosomal abnormalities 2
- Genomics and Rare Diseases 1
- Journals
- Nature Genetics (2 papers)Nature (2 papers)Nature Communications (1 paper)BMC Cancer (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Mark Shackleton
6 papers receiving 1.8k citations
Mark Shackleton's Hit Papers
Peers
Comparison fields: 5 of 83
- Cancer Research 801
- Molecular Biology 1.1k
- Genetics 359
- Pathology and Forensic Medicine 184
- Oncology 247
Countries citing papers authored by Mark Shackleton
This map shows the geographic impact of Mark Shackleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shackleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shackleton more than expected).
Fields of papers citing papers by Mark Shackleton
This network shows the impact of papers produced by Mark Shackleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shackleton. The network helps show where Mark Shackleton may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 550 |
| 2 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 476 |
| 3 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 419 |
| 4 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition Hit paper breakdown → | 2020 | 309 |
| 5 | 2020 | 39 | |
| 6 | 2025 | 1 |
About Mark Shackleton
Mark Shackleton is a scholar working on Cancer Research, Genetics, Statistics and Probability, Pathology and Forensic Medicine and Molecular Biology, having authored 6 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Genomic variations and chromosomal abnormalities (2 papers), CRISPR and Genetic Engineering (1 paper), Genomics and Phylogenetic Studies (1 paper), RNA Research and Splicing (1 paper), Statistical Methods in Clinical Trials (1 paper), Genomics and Chromatin Dynamics (1 paper) and Genomics and Rare Diseases (1 paper). The work is most often cited by research in Cancer Research (801 citations), Molecular Biology (1.1k citations), Genetics (359 citations), Pathology and Forensic Medicine (184 citations) and Oncology (247 citations). Mark Shackleton has collaborated with scholars based in United States, Canada and Germany. Their work appears in journals such as Nature Genetics, Nature, Nature Communications and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.